The Precision Peptide Genetic Test examines 150+ genetic insights across 14 pathways and 49 peptides, including GLP1R variants that influence how your body responds to semaglutide therapy
"It has changed my eating habits, though, I think permanently
Sodium-glucose transporters (SGLT)-inhibitors The treatment of T2DM with glyflozines, sodium-glucose co-transporter 2 inhibitors, represents a new therapeutic approach ( Among SGLT2 inhibitors, three of them have been approved by the FDA and EMA: canagliflozin (2013), dapagliflozin (2014) and empagliflozin (2014)
Gene expression studies and targeted metabolomics reveal disturbed serine, methionine, and tyrosine metabolism in early hypertensive nephrosclerosis
Rotating injection sites between abdomen, thigh, and upper arm prevents localized reactions